Evidence map›Paper›PMID 32028070›Full record

ArticleEBioMedicine2020

Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration.

Katherine J Wert, Gabriel Velez, Vijaya L Kanchustambham, Vishnu Shankar, Lucy P Evans, Jesse D Sengillo, Richard N Zare, Alexander G Bassuk, Stephen H Tsang, Vinit B Mahajan

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07269704 (Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease), which is not on this map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07269704 early_phase1completednot on this mapstarted 2023, after this paper: background citation

Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease: An Open Label, Single Arm Study to Evaluate the Effect of Alpha-ketoglutarate Administered Orally in Patients With Age-related Ocular Diseases (Metabolic Eye Therapy)

TypeinterventionalSponsorStanford UniversityRan2023 to 2025Enrolled17ConditionsEye DiseasesArmsCalcium alpha-ketoglutarate
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Metabolomics in Age-Related Macular Degeneration: A Systematic Review.Investigative ophthalmology & visual science · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Context-Dependent Effects of the Ketogenic Diet on Retinal Ganglion Cell Survival and Axonal Regeneration After Optic Nerve Injury.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  19. Article
  20. Mass spectrometry-based retina proteomics.Mass spectrometry reviews · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Katherine J WertOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States.
Gabriel VelezOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Vijaya L KanchustambhamDepartment of Chemistry, Stanford University, Stanford, CA 94305, United States.
Vishnu ShankarDepartment of Chemistry, Stanford University, Stanford, CA 94305, United States.
Lucy P EvansDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Jesse D SengilloBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Richard N ZareDepartment of Chemistry, Stanford University, Stanford, CA 94305, United States.
Alexander G BassukDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Stephen H TsangEdward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032, United States; Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States; Department of Pathology & Cell Biology, Stem Cell Initiative (CSCI), Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States.
Vinit B MahajanOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States. Electronic address: vinit.mahajan@stanford.edu.
Stanford University · USUniversity of Iowa · USColumbia University · USSmith-Kettlewell Eye Research Institute · USUniversity of Miami · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

backgroundNeurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome.

methodsWe analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle.

findingsDietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle).

interpretationThis study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network.

fundingNIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082.

Indexed as

Liquid BiopsyProteomeProteomicsAnimalsCell DeathCell SurvivalChromatography, LiquidCyclic Nucleotide Phosphodiesterases, Type 6Dietary SupplementsDisease Models, AnimalDisease ProgressionElectroretinographyEye ProteinsFemaleHumansMaleCyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsPde6a protein, mouseProteomeɑ-ketoglutarateDesorption electrospray ionization mass spectrometryKetogenic dietMetabolite supplementationMetabolomicsTCA cycle

Identifiers

PMID32028070
PMCPMC7005447
OpenAlexW3004575133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.